Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020246 |
---|---|
Receipt number | R000023374 |
Scientific Title | Safety evaluation of the preemptive immune-cell therapy against cancer |
Date of disclosure of the study information | 2015/12/21 |
Last modified on | 2020/03/19 18:26:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/12/17 11:45:56 | ||
2 | Update | 2015/12/21 09:46:17 | Recruitment status |
|
3 | Update | 2017/03/17 18:44:27 | Name of primary person or sponsor Organization |
|
4 | Update | 2017/08/31 11:08:22 | Recruitment status |
|
5 | Update | 2017/10/04 10:35:01 | Co-sponsor Co-sponsor Institutions |
|
6 | Update | 2017/10/18 11:18:03 | Recruitment status |
|
7 | Update | 2017/12/19 04:11:31 | Key exclusion criteria Key exclusion criteria |
|
8 | Update | 2018/10/03 21:15:37 | Organization Organization Organization Organization Address Address Organization Organization Address Address Institute Institute Co-sponsor Co-sponsor Organization1 Institutions |
|
9 | Update | 2019/03/27 22:33:19 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Co-sponsor Co-sponsor Organization Organization Address Address Tel Institutions |
|
10 | Update | 2019/03/27 22:37:26 | Date of IRB Last follow-up date |
|
11 | Update | 2019/07/05 10:44:58 | Co-sponsor Co-sponsor Institutions |
|
12 | Update | 2020/03/19 18:14:15 | Co-sponsor Co-sponsor Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Institutions |
|
13 | Update | 2020/03/19 18:15:09 | Recruitment status Other related information Other related information |
|
14 | Update | 2020/03/19 18:26:34 | Other related information Other related information |